Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis
about
Opioids: an unexplored option for treatment of dyspnea in IPFIdiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challengesUpdate on diagnosis and treatment of idiopathic pulmonary fibrosisAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementAn official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.Nebulised morphine for severe interstitial lung disease.Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory responsePatients with End-stage Interstitial Lung Disease may have More Problems with Dyspnea than End-stage Lung Cancer Patients.Therapeutic update in idiopathic pulmonary fibrosis.Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.Symptom-based management of the idiopathic interstitial pneumonia.Advances in the treatment of idiopathic pulmonary fibrosis.Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers.Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in patients with terminally ill cancer: a retrospective study.Opioid use in end-of-life care in patients with interstitial pneumonia associated with respiratory worsening.Idiopathic pulmonary fibrosis: An updateDanish respiratory society position paper: palliative care in patients with chronic progressive non-malignant lung diseases
P2860
Q26766233-12B6B556-025B-413C-B582-5ACFEA186625Q27499290-9A7EDE03-4A9C-4D6B-BB2F-768035FB7A16Q28083702-8D015D31-2532-4320-A53D-F7DF0C09DCD2Q28308246-F530B067-6972-4449-9AFE-78D307A350EEQ33738878-FEAED690-0D11-4176-95DA-5691C0088648Q34758130-3097B91C-D200-4754-AB04-6343F0F24338Q35528427-81D24E23-05F6-403D-92FE-2935C0C6F219Q37151821-B55A1747-AA6E-4ABC-95DC-58369DCD61B0Q37827436-AEBC258A-D1FC-42E3-892B-7A70D5CE5686Q38064381-2C731515-A8E9-4C24-989F-B86743471354Q38602725-EAD29889-FDFB-4F6E-A3AE-B9CF65EBEBA8Q38656594-563E2CE2-C49B-4A52-8FB8-ADB8D3257D54Q38809509-73DE0E15-CD08-4E2D-B0DB-757475D89608Q38987215-70A12DC2-2CCC-4731-8F4C-CFA16A01DF71Q39246764-74B9B2BB-978E-4744-A60C-7E3FCDA9F744Q44341042-36B1F372-DC27-486D-99E7-C08C959D49CAQ57762744-94623E98-6011-4F58-B2F8-BD599C25BB1FQ57814235-923D4305-9DD0-46B4-B4B9-59ECB16A156D
P2860
Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Low dose diamorphine reduces b ...... idiopathic pulmonary fibrosis
@ast
Low dose diamorphine reduces b ...... idiopathic pulmonary fibrosis
@en
type
label
Low dose diamorphine reduces b ...... idiopathic pulmonary fibrosis
@ast
Low dose diamorphine reduces b ...... idiopathic pulmonary fibrosis
@en
prefLabel
Low dose diamorphine reduces b ...... idiopathic pulmonary fibrosis
@ast
Low dose diamorphine reduces b ...... idiopathic pulmonary fibrosis
@en
P2093
P2860
P3181
P1433
P1476
Low dose diamorphine reduces b ...... idiopathic pulmonary fibrosis
@en
P2093
Jane Woollard
Michael Vassallo
Satru Raut
Stephen Allen
P2860
P304
P3181
P356
10.1191/0269216305PM998OA
P577
2005-02-01T00:00:00Z